CaixaBank, S.A.’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.29M Hold
17,136
– – 0.04% 212
2026
Q2
$9.28M Buy
17,136
+755
+5% +$425K 0.04% 217
2026
Q1
$9.7M Buy
+16,381
New +$8.16M 0.05% 204
2025
Q4
– Sell
-2,058
Closed -$863K – 466
2025
Q3
$863K Hold
2,058
– – ﹤0.01% 341
2025
Q2
$590K Hold
2,058
– – ﹤0.01% 367
2025
Q1
$634K Buy
2,058
+272
+15% +$93.2K ﹤0.01% 366
2024
Q4
$631K Buy
1,786
+874
+96% +$321K ﹤0.01% 347
2024
Q3
$328K Buy
+912
New +$308K ﹤0.01% 379

Other funds holding UTHR

CaixaBank, S.A.'s UTHR Position: Q3 2026 in Review

CaixaBank, S.A. held its United Therapeutics (UTHR) position steady in Q3 2026 at 17,136 shares worth $9.29M. The position accounts for 0.04% of the portfolio, ranked #212.

CaixaBank, S.A. first reported a position in UTHR in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.7M in Q1 2026. 846 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • CaixaBank, S.A. held 17,136 shares of United Therapeutics worth $9.29M as of Q3 2026.
  • CaixaBank, S.A. left its United Therapeutics share count unchanged in Q3 2026.
  • United Therapeutics made up 0.04% of CaixaBank, S.A.'s portfolio in Q3 2026, its #212 holding.
  • CaixaBank, S.A. first reported a position in United Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • CaixaBank, S.A.'s United Therapeutics position peaked at $9.7M in Q1 2026.
  • 846 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.